ZW251
Phase 1Recruiting 0 watching 0 views this week💤 Quiet
28
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hepatocellular Carcinoma
Conditions
Hepatocellular Carcinoma
Trial Timeline
Oct 21, 2025 → May 1, 2028
NCT ID
NCT07164313About ZW251
ZW251 is a phase 1 stage product being developed by Zymeworks for Hepatocellular Carcinoma. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07164313. Target conditions include Hepatocellular Carcinoma.
Hype Score Breakdown
Clinical
10
Activity
5
Company
5
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07164313 | Phase 1 | Recruiting |
Competing Products
20 competing products in Hepatocellular Carcinoma